Advertisement

Pflügers Archiv

, Volume 355, Issue 3, pp 189–204 | Cite as

Inhibition of cell division and the development of denervation hypersensitivity in skeletal muscle

  • R. J. Blunt
  • Rosemary Jones
  • Gerta Vrbová
Article

Summary

  1. 1.

    It was found that in 3 day denervated soleus and EDL muscles nuclear division takes place. This can be stopped by administration of either 5-fluoro-uracil or vincristine.

     
  2. 2.

    The increased sensitivity to acetylcholine following denervation developed at a time when rapid cell division takes place. Both 5-fluoro-uracil and vincristine prevent the development of denervation hypersensitivity both in soleus and EDL muscles.

     
  3. 3.

    Muscle injury causes some cell division locally, but some phagocytic cells that infiltrate the damaged muscle appear to be blood-borne as their appearance within the muscle is not entirely prevented by either 5-fluoro-uracil or vincristine. Correspondingly the development of increased sensitivity that follows muscle injury is only partly prevented by administration of cytotoxic drugs.

     
  4. 4.

    It is suggested that the presence of dividing cells is causally related to the development of denervation hypersensitivity.

     

Key words

Cell Division Denervated Muscle Hypersensitivity 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abercrombie, M., Johnson, M. L.: Quantitative histology of wallerian degeneration. 1. Nuclear population in rabbit sciatic nerve. J. Anat. (Lond.)80, 37–50 (1946)Google Scholar
  2. Albuquerque, E. X., Warnick, J. E., Tasse, J. R., Sansone, F. M.: Effects of vin, blastine and colchicine on neural regulation of the fast and slow skeletal muscles of the rat. Exp. Neurol.37, 607–634 (1972)Google Scholar
  3. Anderson, P. J., Song, S. K., Slotwiner, W.: Spheromembranous degeneration produced by vincristine. J. Neuropath. exp. Neurol.26, 15–24 (1967)Google Scholar
  4. Axelsson, J. Thesleff, S.: A study of supersensitivity in denervated mammalian skeletal muscle. J. Physiol. (Lond.)147, 178–193 (1959)Google Scholar
  5. Blunt, R. J., Jones, R.: Inhibition of cell division and denervation hypersensitivity in skeletal muscle. J. Physiol. (Lond.)226, 99–100P (1972)Google Scholar
  6. Diamond, J., Miledi, R.: A study of foetal and new born rat muscle fibres. J. Physiol. (Lond.)162, 393–408 (1962)Google Scholar
  7. Fambrough, D. M.: Acetylcholine sensitivity of muscle fibre membranes: mechanism of regulation by motoneurones. Science168, 372–378 (1970)Google Scholar
  8. Fambrough, D., Rash, J. E.: Development of acetylcholine sensitivity during myogenesis. Rev. Biol.26, 55–68 (1971)Google Scholar
  9. Ginetzinski, A. G., Shamarina, N. M.: The tonomotor phenomenon in denervated muscles. Usp. sovrem. Biol.15, 283–294 (1942)Google Scholar
  10. Goodman, L. S., Gillman, A.: The pharmacological basis of therapeutics, 3rd Ed. Ch. 62, Section XV, Chemotherapy of neoplastic diseases. New York: Macmillan Co. 1966Google Scholar
  11. Grampp, W., Harris, J. B., Thesleff, S.: Inhibition of denervation changes in skeletal muscle by blockers of protein synthesis. J. Physiol. (Lond.)221, 743–754 (1972)Google Scholar
  12. Gutmann, E., Hájek, I., Syrový, I.: Proteloytic activity in denervated and reinnervated muscle. Physiol. bohemoslov.13, 32–38 (1964)Google Scholar
  13. Gutmann, E., Vodička, A., Zelená, J.: Changes in the striated muscle after nerve section related to the length of the peripheral stump. Physiol. bohemoslov.4, 200 (1955)Google Scholar
  14. Gutmann, E., Young, J. Z.: The reinnervation of muscle after various periods of atrophy. J. Anat. (Lond.)78, 15–43 (1944)Google Scholar
  15. Heidelberger, L.: Fluorinated pyrimides. Progr. Nucl. Acid Rev.4, 1–50 (1965)Google Scholar
  16. Jones, R., Vrbová, G.: Two factors responsible for denervation hypersensitivity. J. Physiol. (Lond.)236, 517–538 (1974)Google Scholar
  17. Katz, B., Miledi, R.: The development of ACh sensitivity in nerve free segments of skeletal muscle. J. Physiol. (Lond.)170, 389–396 (1964)Google Scholar
  18. Kuffler, S. W.: Specific excitability of the endplate region in normal and denervated muscle fibres. J. Neurophysiol.6, 99–110 (1943)Google Scholar
  19. Luco, J. V., Eyzaguirre, C.: Fibrillation and hypersensitivity to ACh in denervated muscle. Effect of length of degenerating nerve fibres. J. Neurophysiol.18, 65–73 (1955)Google Scholar
  20. Lunt, G. G., Stephani, E., De Robertis, E.: Increased incorporation of G-3H leucine into possible “receptor” proteolipid in denervated muscle in vivo. J. Neurochem.18, 1545–1553 (1971)Google Scholar
  21. Malawista, S. E., Sato, H., Bensch, K. G.: Vinblastine and griseofulvin reversibly disrupt the living mitotic spindle. Science160, 770–771 (1968)Google Scholar
  22. Miledi, R.: Junctional and extrajunctional acetylcholine receptors in skeletal muscle fibres. J. Physiol. (Lond.)151, 24–30 (1960a)Google Scholar
  23. Miledi, R.: The acetylcholine sensitivity of frog muscle fibres after complete or partial denervation. J. Physiol. (Lond.)151, 1–23 (1960b)Google Scholar
  24. Miledi, R., Slater, C. R.: On the degeneration of rat neuromuscular junctions after nerve section. J. Physiol. (Lond.)207, 507–528 (1969)Google Scholar
  25. Miledi, R., Zelená, J.: Sensitivity to ACh in rat slow muscle. Nature (Lond.)210, 855–856 (1966)Google Scholar
  26. Nastuk, W. L.: Membrane potential changes at a single muscle endplate produced by transitory application of ACh with an electrically controlled micro-jet. Fed. Proc.12, 102 (1953)Google Scholar
  27. Pilar, G., Landmesser, L.: Axotomy mimicked by localized colchicine application. Science177, 1116–1118 (1972)Google Scholar
  28. Reznik, M.: Origin of myoblasts during skeletal muscle regeneration. Electron microscopic observations. Lab. Invest.20, 353–363 (1969)Google Scholar
  29. Rogers, A. W.: In: Techniques of Autoradiography. Ch. 15: Liquid emulsion techniques for grain density autoradiography, pp. 235–272. Amsterdam-London-New York: Publ. Elservier 1967Google Scholar
  30. Spector, W. G., Willoughby, D. A.: In: The pharmacology of inflammation. Ch. 2: The inflammatory reaction, pp. 8–21. London: Univ. Press 1968Google Scholar
  31. Thesleff, S.: Physiological effects of denervation of muscle. Am. N. Y. Acad. Sci.228, 89–104 (1974)Google Scholar
  32. Vrbová, G.: Induction of an extrajunctional chemosensitive area in intact innervated muscle fibres. J. Physiol. (Lond.)191, 20–21P (1967)Google Scholar
  33. Vrbová, G.: Control of chemosensitivity at the neuromuscular junction. Proc. IVth Internat. Congress on Pharmacol., Vol. III, pp. 158–169. Basel-Stuttgart: Schwabe & Co. 1969Google Scholar
  34. Walter, J. B., Israel, M. S.: In: General Pathology. Ch. 7: The inflammatory reaction, p. 97 London; Univ. Press 1970Google Scholar
  35. Wisniewski, H., Shelanski, M. L., Terry, R. D.: Effects of mitotic spindle inhibitors on neurotubules and neurofilaments in anterior horn cells. J. Cell Biol.38, 224–229 (1968)Google Scholar

Copyright information

© Springer-Verlag 1975

Authors and Affiliations

  • R. J. Blunt
    • 1
  • Rosemary Jones
    • 1
  • Gerta Vrbová
    • 1
  1. 1.Department of PhysiologyThe Medical SchoolBirminghamEngland

Personalised recommendations